‹ Back To Others
Oxford Immunotec, Inc.
SummaryOxford Immunotec received a $100,000 grant from the Tennessee FastTrack Economic Development Fund. The Tennessee FastTrack Economic Development Fund provides additional grant support for companies expanding or locating in Tennessee with reimbursable grants made to local industrial development boards. EDGE acted as a conduit for the grant.
Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The Company's first product is the T-SPOT.TB test, which is used to test for tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company's second product line is a range of assays for tick-borne diseases, such as Lyme disease. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass.
Projected Total Jobs: